KDL recognized for quality, receives re-accreditation from CAP. Read more

News and Events

Cancer survivors may be at higher risk of developing Melanoma. Read report

Latest studies suggest Melanoma is costlier and cuts life shorter than other cancers. Story

Diagnostic Update

KDL now providing FDA-approved BRAF testing for all mestastic melanomas. More

Contact Us

800.772.0951
865.584.1933
clientservices@kdlpathology.com
facebook icon

Stay Connected

Receive the DermPath Update or hear the latest news from KDL Pathology.